Pharmacy/Pharmacology - What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?
Can't see this email? View it online
   
  Pharmacy / Pharmacology  
  The latest pharmacy / pharmacology news from News Medical  
 

Pharmaceutical Dispersions: Shelf-Life and Redispersion PropertiesPharmaceutical Dispersions: Shelf-Life and Redispersion Properties

Advances in vaccine and drug development face challenges in encapsulation and targeting. Carriers protect drugs, aiding targeting and assimilation, but their instability can cause issues like phase separation, incorrect dosages, and loss of specific surfaces. Turbiscan Technology provides a non-dilution, native measurement of shelf-life (particle size and migration). It can assess a suspension's recovery rate and ability to regain initial properties after shaking/mixing before use.

Read The Guide
 
   What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?
 
Researchers assessed the safety and efficacy of danuglipron in type 2 diabetes (T2D) patients.
 
   Insight into Next-Generation Protein TherapeuticsInsight into Next-Generation Protein Therapeutics
 
Next-generation protein therapeutics have become popular amongst researchers, especially after the emergence and development of novel COVID-19 vaccines, including mRNA vaccines, that thrust this concept into the spotlight at a global scale.
 
 Revolutionizing Schizophrenia Research with the Queensland Brain Institute
 
Revolutionizing Schizophrenia Research with the Queensland Brain InstituteTo commemorate World Schizophrenia Awareness Day, we spoke to three researchers from the Queensland Brain Institiute about their research, and why it is so important to raise awareness around Schizophrenia
 
 
 New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindness
 
New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindnessIn a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).
 
 
 Hormone replacement therapy for treating menopausal symptoms: Benefits and risks
 
Hormone replacement therapy for treating menopausal symptoms: Benefits and risksHot flashes, night sweats and sleep disturbances are common symptoms of menopause that can affect health, quality of life and work productivity.
 
 
 Valbenazine improves chorea associated with Huntington's disease
 
Valbenazine improves chorea associated with Huntington's diseaseThe drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington's disease, when compared to a placebo, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served as principal investigator on behalf of the KINECT-HD Huntington Study Group.